The story of Viagra, formerly marketed by copyright, presents a complex case study for stakeholders considering the healthcare sector. Although its groundbreaking success and impact of countless in sales, the exclusivity end has opened the way for competing medications, significantly reducing profit prospects . This shift raises questions about the